Breast Neoplasms: all 12,820 studies
Page 6 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Luminal Breast Cancer CryoablationRecruitingNCT07447414Not applicable
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialRecruitingNCT07447050Phase 2
- Ultrasound-Guided SPSIP Versus ESPB for Postoperative Pain After Modified Radical MastectomyRecruitingNCT07446868Not applicable
- Study on the Safety and Tolerability of Postoperative Radiotherapy Concurrent With CDK4/6 Inhibitors in HR+/HER2- High-Risk Breast CancerNot yet recruitingNCT07446686Early Phase 1
- A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low ExpressionNot yet recruitingNCT07446049Phase 2
- Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.RecruitingNCT07443774
- Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance MammographyRecruitingNCT07443579Not applicable
- HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)RecruitingNCT07441889Phase 1/2
- Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer PatientsRecruitingNCT07441733Not applicable
- A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast CancerNot yet recruitingNCT07441486Phase 2
- Food-related Quality of Life in Patients With CancerNot yet recruitingNCT07437326
- Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DICRecruitingNCT07436663Phase 4
- Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of CancerRecruitingNCT07436312Not applicable
- CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）RecruitingNCT07432178Phase 3
- Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for CancerRecruitingNCT07429487Not applicable
- Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and AbemaciclibNot yet recruitingNCT07428018Phase 2
- Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy MarkersNot yet recruitingNCT07427407
- Weight Management After Cancer for Survivors in Rural CommunitiesRecruitingNCT07426952Not applicable
- Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or TrastuzumabRecruitingNCT07426913Not applicable
- Margin Optimisation Using Z-axis Assessment With Real-time Tomosynthesis (MOZART Study).RecruitingNCT07426809Not applicable
- IRIS: Risk-Based Imaging After Breast-Conserving SurgeryNot yet recruitingNCT07426510Not applicable
- Evaluation of Quality of Life After Facial Hyaluroic Acid Injections Following Treatment for Breast Cancer.Not yet recruitingNCT07425548Not applicable
- Prehabilitation in Breast Cancer SurgeryNot yet recruitingNCT07425379Not applicable
- Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM)RecruitingNCT07425002Not applicable
- Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsRecruitingNCT07424547Phase 1
- ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast CancerNot yet recruitingNCT07423611Phase 2
- A Platform Study Based on Specific Tracer for Evaluating the Therapeutic Efficacy of Systemic Treatment for Breast Cancer Using PET/MRINot yet recruitingNCT07419867Phase 2
- Grape Polyphenols for Prevention of Chemotherapy-Induced CardiotoxicityNot yet recruitingNCT07419711Not applicable
- Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIARecruitingNCT07418125Not applicable
- Evaluation of the Impact of Pre-habilitation Using Physiotherapy and Mechanical Stimulation on Shoulder Pain and Mobility in Patients Undergoing Breast Reconstruction Using a Latissimus Dorsi FlapRecruitingNCT07418060Not applicable
- SHR-A1811 vs Pyrotinib/Capecitabine in Trastuzumab-Resistant HER2+ Advanced Breast Cancer: A Randomized StudyNot yet recruitingNCT07417241Phase 2
- Web-Based Application for Monitoring Radiation Therapy Complications in Cancer PatientsRecruitingNCT07416630Not applicable
- Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast CancerNot yet recruitingNCT07416253Phase 2
- Breast Density Impact on Mammographic Screening for Breast Cancer DiagnosisRecruitingNCT07415499
- Pedicled Lateral Chest Wall Lymph-Adipofascial Flap to Prevent Arm Lymphedema After Breast Cancer SurgeryNot yet recruitingNCT07415200Not applicable
- Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Response BiomarkersNot yet recruitingNCT07411651Not applicable
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsRecruitingNCT07410676Phase 1/2
- Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Breast CancerNot yet recruitingNCT07410559Phase 2
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant ChemotherapyNot yet recruitingNCT07410234Phase 2
- Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral NeuropathyRecruitingNCT07410169Phase 2/3
- Multicomponent Care for Aromatase Inhibitor-Related Musculoskeletal SymptomsNot yet recruitingNCT07409948Not applicable
- Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor TherapyEnrolling by invitationNCT07409298Not applicable
- Adjuvant Intensification for LARNot yet recruitingNCT07407517Phase 3
- Real-world Studies of CDK4/6 InhibitorsRecruitingNCT07407439
- Triaging of Women Detected With a Breast Lump on Clinical Breast Examination Using Portable Ultrasound DeviceRecruitingNCT07407153Not applicable
- Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs).RecruitingNCT07406789Phase 2
- Gut Microbiome Changes During Abemaciclib Therapy in Breast CancerNot yet recruitingNCT07406594Not applicable
- A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast CancerNot yet recruitingNCT07406542Phase 3
- Nonpharmacological Management of Pain and Fear During Hormone Injection in Breast Cancer PatientsNot yet recruitingNCT07406165Not applicable
- Navigation Intervention for Adolescent and Young Adult Cancer SurvivorsRecruitingNCT07406087Not applicable
- Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer PatientsRecruitingNCT07405931Not applicable
- A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast CancerRecruitingNCT07405801Phase 2
- REstoring Metabolic FLEXibility Through Combined Exercise in Breast Cancer Survivors: A Randomized Controlled Trial.Not yet recruitingNCT07405385Not applicable
- Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast CancerRecruitingNCT07401537Phase 2
- A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast CancerRecruitingNCT07401381Phase 1
- Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant ChemotherapyRecruitingNCT07400523Phase 3
- CDK4/6 Inhibitors in Breast Cancer Elderly Patients: an Observational Ambispective Longitudinal Multicenter StudyRecruitingNCT07399808
- CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer.Not yet recruitingNCT07398118Not applicable
- Pilot Observational Study of an Integrative Cure Stay ProgramRecruitingNCT07398079
- stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective DatabaseRecruitingNCT07397585
- Elacestrant and Exemestane for Patients With Pretreated HR+/HER2- Metastatic Breast Cancer and [18F] FES-avid Lesions (COMBINE)RecruitingNCT07395336Phase 2
- Neoadjuvant Letrozole in Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative, Node Positive, Early-Stage Breast Cancer.Not yet recruitingNCT07394946Phase 2
- ctDNA-guided Treatment Decision-makingRecruitingNCT07394218Phase 2
- Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast CancerRecruitingNCT07393425Phase 2
- A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast CancerNot yet recruitingNCT07393321Phase 3
- BreastCancerPEP: A Six-Month Online Empowerment Program to Improve Mental and Physical Health in Women With Breast CancerNot yet recruitingNCT07392424Not applicable
- A Study of SH009 Injection in Patients With Advanced Solid Tumors.RecruitingNCT07390838Phase 1
- Rhomboid Intercostal Sub-serratus Plane Blocks and Erector Spinae Plane Block in Mastectomy SurgeriesRecruitingNCT07390448Not applicable
- Nutrition Awareness Among Women With Non-Metastatic Breast CancerRecruitingNCT07389967Not applicable
- A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® TestingRecruitingNCT07389408
- Application of Multimodal MRI-based Radiomics in Histological Grading and Prognostic Assessment of Breast CancerNot yet recruitingNCT07389200
- PI3K Pathway Activation Markers in ER-Positive, HER2-Negative Breast Cancer: A Clinicopathologic StudyNot yet recruitingNCT07387861
- Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.RecruitingNCT07387445Not applicable
- Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic TestingRecruitingNCT07387263Not applicable
- A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast CancerNot yet recruitingNCT07385365Phase 3
- Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)RecruitingNCT07383818Phase 2
- A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid TumorsRecruitingNCT07383506Phase 1
- Famitinib Combined With SHR-A1811, Versus SHR-A1811 for CDK4/6 Inhibitors-resistent Advanced HR+/HER2- Breast Cancer With SNF4 SubtypeNot yet recruitingNCT07382687Phase 3
- Developing a Comprehensive Exercise Service for Breast Cancer ProcessRecruitingNCT07380971
- the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast CancerRecruitingNCT07380646Phase 2
- Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer PatientsNot yet recruitingNCT07380230Not applicable
- Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast CancerRecruitingNCT07379918
- Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness.RecruitingNCT07378319Not applicable
- FMD and Neoadjuvant Chemo-immunotherapy in TNBCRecruitingNCT07378306Phase 2
- Acupuncture and Compression for the Prevention of CIPN in Breast Cancer PatientsRecruitingNCT07377279Not applicable
- Fertility Outcomes In Young Breast Cancer Patients And Their Prognosis And Offspring HealthEnrolling by invitationNCT07376681
- Response-Based Local Therapy for Regionally Advanced Breast CancerRecruitingNCT07376538Phase 2
- The Prognostic Impact of HER2 Expression in Non-Metastatic HER2-Positive Breast Cancer Treated With Dual HER2-Targeted TherapyRecruitingNCT07376174
- Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast CancerNot yet recruitingNCT07374796
- Effect of Esketamine on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Severe DepressionNot yet recruitingNCT07374211Not applicable
- Effect of Continuous Intraoperative Esketamine Infusion on Perioperative Negative Emotions in Breast Cancer Surgery Patients With Mild-to-Severe DepressionNot yet recruitingNCT07374198Not applicable
- Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast CancerRecruitingNCT07373782Phase 2/3
- Comparison of Breast Sensory Recovery Between Conventional and Endoscopic Nipple-Sparing Mastectomy Combined With Prepectoral Implant ReconstructionNot yet recruitingNCT07372339Not applicable
- Creatine and Cognitive Health in Patients With Early-stage Breast Cancer During and After Chemotherapy TreatmentNot yet recruitingNCT07372144Phase 3
- Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and Tuvonralimab Injection in Combination With ChemotherapyRecruitingNCT07372079Phase 2
- PERsonalized Mammographic Screening in NorwayNot yet recruitingNCT07371702
- Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity ManagementRecruitingNCT07371585Phase 2
- Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast CancerRecruitingNCT07371208Phase 2
- NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE)Not yet recruitingNCT07370571